This report represents a preliminary attempt to characterise photoaversion in RP, which we define as symptomatic interference with visual performance due to exposure to bright light. RP patients were surveyed to discover the frequency and nature of complaints, and presented with a variety of psychophysical tests to define and quantify the symptom of 'photoaversion'.
The most prominent symptoms of retinitis pigmentosa (RP) are progressive night blindness and field loss, though central vision may also be reduced. Many patients complain of difficulty in functioning in bright light (noted anecdotally by Leber in 1916'), but to our knowledge there has been no documentation of the frequency, characteristics, or physiology of such symptoms. This report represents a preliminary attempt to characterise photoaversion in RP, which we define as symptomatic interference with visual performance due to exposure to bright light. RP patients were surveyed to discover the frequency and nature of complaints, and presented with a variety of psychophysical tests to define and quantify the symptom of 'photoaversion'.
Material and methods
A total of 20 photoaversive RP patients (11 male, 9 female) performed psychophysical tests (though no subject performed all tests). The age range was 11-68 (average 34); visual acuity ranged from 20/20 to 20/70. RP To survey for symptoms we contacted personally all our RP patients whose records (within 10 years) indicated 20/200 or better acuity and basically clear media, and who could be reached within a two-week study period. A total of 22 reported functional reading ability and no cataract to their knowledge; seven were in the group undergoing experimental studies. We also surveyed 19 normal people of similar ages.
CONTRAST SENSITIVITY AND GLARE TESTS Contrast sensitivity at distance was measured monocularly, in the presence and absence of glare, with Vistech charts (Vistech Consultants, Inc.). These consist of three large posters with sine-wave gratings of varying spatial frequency and contrast whose orientation may be vertical or tilted.2 Illumination was as in the manufacturer's specifications. The 
CONTRAST SENSITIVITY AND GLARE SENSITIVITY
The contrast sensitivity of seven RP patients and seven normal controls was tested at 10 feet (3 m) with Vistech posters while looking through a circular fluorescent bulb as a source of peripheral glare. Fig. 2 shows contrast sensitivity (plotted against spatial frequency) with the light on and off. RP subjects showed lower contrast sensitivity than normal people under either condition, and a roughly 0 1 log unit greater decrement in contrast sensitivity in the presence ofglare. Further to evaluate glare effects we tested nine RP and six normal subjects using the Miller-Nadler glaretester. Normal people had little difficulty with the test (only one missed one target), and the RP patients on average missed only the two most subtle targets in the presence of glare, corresponding (according to manufacturer's data) to a 5% glare disability. With the peripheral glare source masked off, a subgroup of six RP and four normal subjects recognised all of the targets.
DISCOMFORT AND PHOTOSTRESS
The results of central photostress and peripheral bright light testing of nine normal and four RP subjects are presented in Fig. 3 . The scattergrams show the time for recovery of vision to 1 line above normal acuity. The RP patients generally had longer recovery times; after peripheral light exposure all the normal persons recovered visual function immediately, whereas only one of the four RP subjects had no period of delay. The scattergrams in Fig. 4 show the intensity of binocular illumination, presented either centrally or peripherally, at which subjects perceived discomfort. The discomfort levels of normals versus RP patients were not categorically different, and some RP patients were even more tolerant of bright light than the controls (despite the general complaint of photoaversion). Results from monocular testing were similar.
DARK ADAPTATION IN PHOTOSENSITIVE SUBJECTS
Data on the first 1-2 seconds of dark adaptation from five RP patients and seven normal subjects are presented in Fig. 5 . RP subjects had higher thresholds than normals both before and after turning off the adapting light; however, the rate of early dark adaptation differed very little, if at all. We also tested (for three RP subjects and two normals) the speed of adaptation between levels of photopic background illumination roughly 2 log units apart (Fig. 6) . RP patients had higher baseline thresholds at either level of illumination than normal people, but the recovery of sensitivity on lowering the background intensity was almost immediate for both groups.
Discussion
Clinicians are aware that many RP patients complain bitterly of visual impairment or of discomfort in bright light, but we could find no reports on the frequency or severity of this symptom or its pathophysiology (in the absence of a scattering source such as cataract). This report represents a preliminary attempt at resolving these issues. The number of patients studied was small, but our purpose was to seek major differences between RP patients and normal persons and study as many conditions as possible, rather than to evaluate any specific test exhaustively. Our survey confirms the clinical impression that SUBJECTIVE DISCOMFORT TEST photoaversion is a significant complaint in RP independent of symptoms from cataract. We have used the term 'photoaversion', since 'light sensitivity' is somewhat ambiguous (sensitivity refers to both thresholds and discomfort) and 'photophobia' is used for conditions that produce pain such as iritis. We asked patients about 'sensitivity to light', but the meaning is unambiguous in this colloquial context. Nearly all the 22 RP patients surveyed considered themselves to be light-sensitive, had difficulty in functioning in bright sun, and had difficulty recovering sensitivity after such exposure. Our psychophysical results show that it is not so easy to find quantitative confirmation or definition of these subjective symptoms.
Our study of visual recovery from photostress showed that RP patients require a longer time to recover visual acuity following a bright stress (either peripheral or central) than normal persons. However, we could not detect any difference between PHOTOPIC ADAPTATION RP NORMAL TIME (minutes) patients and normals in the rate at which dark adaptation began. The common complaint of difficulty coming indoors may be explained by the fact that RP patients require a greater degree of adaptation before their vision finally (if ever) reaches a functional level, even though the actual rate at which photopic dark adaptation proceeds is not unusual. The functional difficulties which RP patients describe in bright light are harder to explain. Contrast sensitivity was reduced by bright light somewhat more in RP subjects than in normal people, but this difference seems unlikely to account by itself for the symptoms of photoaversion. Furthermore, our subjective discomfort test did not indicate that patients were more sensitive to bright light than normal people despite the subjective complaints. Possibly the symptoms derive from the fact that baseline contrast sensitivity is reduced in RP,17 so that even a minimal further reduction due to bright light may move the patient into a range of functional disability. In other words the problem may be less one of supersensitivity to light than one of limited capacity to suffer a small light-induced decrement of function that would normally be tolerated.
Photoaversion in RP is probably not a simple consequence of photoreceptor saturation or photochemical responsiveness, since subjective discomfort levels and adaptation rates were grossly normal. The symptoms cannot be attributed to cataract, since our subjects lacked this complication-though cataract may add to the difficulties experienced by RP patients. It is possible that our studies missed relevant levels of light intensity or wavelengths in outdoor illumination which we could not duplicate in our indoor experiments. It is also quite possible that photoaversion does not, as a symptom, derive from a single physiological source, but is in fact a composite of a number of causes including glare, photostress, low discomfort threshold, altered increment threshold, and poor baseline contrast sensitivity. Dr Ginsburg is chairman and director of research and development of Vistech Consultants, Inc., which manufactures the Vistech Contrast Sensitivity Charts and the Vistech Multivision Contrast Tester used in some parts of this project. None of the other authors have any proprietary interest in the equipment used. 
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